Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Friday, December 25, 2009, 3:48PM ET - U.S. Markets Closed for Christmas.
Dow
0.51%
Nasdaq
0.71%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
Orthologic Corp. (CAPS)
On
Dec 24
:
0.71
0.02
(2.85%)
MORE ON CAPS
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Headlines
Get
Headlines
for:
Change Display [
hide $$
edit
]
Wed, Apr 22, 2009
Capstone Therapeutics Announces Publication of Second Data Group (Elevated Cholesterol) From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire
(Wed, Apr 22)
Fri, Apr 3, 2009
Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Pilot Study in Keloid Scarring
GlobeNewswire
(Fri, Apr 3)
Fri, Mar 13, 2009
ORTHOLOGIC CORP Files SEC form 10-K, Annual Report
EDGAR Online
(Fri, Mar 13)
Thu, Mar 5, 2009
Capstone Therapeutics Announces Publication of First Data Group From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire
(Thu, Mar 5)
Capstone Therapeutics Announces Publication of First Data Group From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
GlobeNewswire
(Thu, Mar 5)
Wed, Feb 25, 2009
Buy This Undervalued Biotech Now
at TheStreet.com
(Wed, Feb 25)
Tue, Feb 10, 2009
Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Clinical Trial in Dermal Scarring; Management to Host Teleconference and Webcast Today
GlobeNewswire
(Tue, Feb 10)
ORTHOLOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financia
EDGAR Online
(Tue, Feb 10)
Thu, Feb 5, 2009
Capstone Therapeutics to Host Investor Update Teleconference and Webcast February 10, 2009
GlobeNewswire
(Thu, Feb 5)
Older Headlines
-
Most Recent Headlines
View headlines from:
Thu, Feb 5, 2009
Thu, Jan 29, 2009
Thu, Jan 22, 2009
Thu, Jan 15, 2009
Thu, Jan 8, 2009
Thu, Jan 1, 2009
Thu, Dec 25, 2008
Thu, Dec 18, 2008
Thu, Dec 11, 2008
Thu, Dec 4, 2008
Add CAPS News to My Yahoo!:
Add to Portfolio
Set Alert
Email to a Friend
Get
Headlines
for Another Symbol:
Symbol Lookup
Stocks In Play
Story Stocks
Full Coverage